Adler G, Brassen S. Short-term rivastigmine treatment reduces EEG slow-wave power in Alzheimer patients. Neuropsychobiology. 2001;43(4):273-6.
Adler G, Brassen S, Jajcevic A. EEG coherence in Alzheimer's dementia. J Neural Transm. 2003;110(9):1051-8.
Adler G, Brassen S, Chwalek K et al. Prediction of treatment response to rivastigmine in Alzheimer's dementia. J Neurol Neurosurg Psychiatry.
2004;75(2):292-4.
Agnoli A, Martucci N, Manna V et al. Effect of cholinergic and anticholinergic drugs on short-term memory in Alzheimer's dementia: a neuropsychological and computerized electroencephalographic study. Clin Neuropharmacol. 1983;6(4):311-23.
Alhainen K, Partanen J, Reinikainen K et al. Discrimination of
tetrahydroaminoacridine responders by a single dose pharmaco-EEG in patients with Alzheimer's disease. Neurosci Lett. 1991;127(1):113-6.
Balkan S, Yaras N, Mihci E et al. Effect of donepezil on EEG spectral analysis in Alzheimer's disease. Acta Neurol Belg. 2003 Sep;103(3):164-9.
Bennys K, Rondouin G, Vergnes C et al. Diagnostic value of quantitative EEG in Alzheimer's disease. Neurophysiol Clin. 2001;31(3):153-60.
Besthorn C, Forstl H, Geiger-Kabisch C et al. EEG coherence in Alzheimer disease. Electroencephalogr Clin Neurophysiol. 1994;90(3):242-5.
Brassen S, Adler G. Short-term effects of acetylcholinesterase inhibitor treatment on EEG and memory performance in Alzheimer patients: an open, controlled trial. Pharmacopsychiatry. 2003 Nov;36(6):304-8.
Brassen S, Braus DF, Weber-Fahr W et al. Late-onset depression with mild cognitive deficits: electrophysiological evidences for a preclinical dementia syndrome.Dement Geriatr Cogn Disord. 2004;18(3-4):271-7
Brenner RP, Reynolds CF 3rd, Ulrich RF. EEG findings in depressive
pseudodementia and dementia with secondary depression. Electroencephalogr Clin Neurophysiol. 1989;72(4):298-304.
Brunovsky M, Matousek M, Edman A et al. Objective assessment of the degree of dementia by means of EEG. Neuropsychobiology. 2003;48(1):19-26。
Buchan RJ, Nagata K, Yokoyama E et al. Regional correlations between the EEG and oxygen metabolism in dementia of Alzheimer's type. Electroencephalogr Clin
Neurophysiol. 1997 Sep;103(3):409-17.
Centorrino F, Price BH, Tuttle M et al. EEG abnormalities during treatment with typical and atypical antipsychotics. Am J Psychiatry. 2002;159(1):109-15.
Chiaramonti R, Muscas GC, Paganini M et al. Correlations of topographical EEG features with clinical severity in mild and moderate dementia of Alzheimer type.
Neuropsychobiology. 1997;36(3):153-8.
Claus JJ, Ongerboer de Visser BW, Walstra GJ et al. Quantitative spectral electroencephalography in predicting survival in patients with early Alzheimer disease. Arch Neurol. 1998;55(8):1105-11.
Claus JJ, Kwa VI, Teunisse S et al. Slowing on quantitative spectral EEG is a marker for rate of subsequent cognitive and functional decline in early
Alzheimer disease. Alzheimer Dis Assoc Disord. 1998;12(3):167-74.
Coben LA, Danziger WL, Berg L. Frequency analysis of the resting awake EEG in mild senile dementia of Alzheimer type. Electroencephalogr Clin Neurophysiol.
1983;55(4):372-80.
Conti F, Manzoni T. The neurotransmitters and postsynaptic actions of callosally projecting neurons. Behav Brain Res 1994;64: 37–53
Cummings JL. Alzheimer's disease. N Engl J Med. 2004;351(1):56-67.
d'Onofrio F, Salvia S, Petretta V et al. Quantified-EEG in normal aging and dementias. Acta Neurol Scand. 1996;93(5):336-45.
Dierks T, Ihl R, Frolich L et al. Dementia of the Alzheimer type: effects on the spontaneous EEG described by dipole sources. Psychiatry Res. 1993;50(3):151-62.
Duffy FH, McAnulty GB, Albert MS. The pattern of age-related differences in electrophysiological activity of healthy males and females. Neurobiol Aging.
1993;14(1):73-84.
Elmstahl S, Rosen I, Gullberg B. Quantitative EEG in elderly patients with Alzheimer's disease and healthy controls. Dementia. 1994;5(2):119-24.
Fich BJ. Splhemann's EEG Primer. Elsevier. 1991
Folstein, M.F., Folstein, S.E., Mc Hugh, P.R. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975;(12):189-198.
Gauthier S, Reisberg B, Zaudig M et al. Mild cognitive impairment. Lancet.
2006;367(9518):1262-70.
Gersch W, Goddard GV. Epileptic focus location: spectral analysis method.
Science. 1970;169(946):701-2.
Hachinski VC, Iliff LD, Zilhka E. et al. Cerebral blood flow in dementia. Arch.
Neurol. 1975;32:632–637.
Hampel H, Teipel SJ, Alexander GE et al. Corpus callosum atrophy is a possible indicator of region- and cell type-specific neuronal degeneration in Alzheimer disease: a magnetic resonance imaging analysis. Arch Neurol. 1998;55(2):193-8.
Hampel H, Teipel SJ, Alexander GE et al. In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PET. J Neural Transm. 2002;109(5-6):837-55.
Hanyu H, Asano T, Sakurai H et al. Diffusion-weighted and magnetization transfer imaging of the corpus callosum in Alzheimer's disease. J Neurol Sci.
1999;167(1):37-44.
Helkala EL, Laulumaa V, Soininen H et al. Different patterns of cognitive decline related to normal or deteriorating EEG in a 3-year follow-up study of patients with Alzheimer's disease. Neurology. 1991;41(4):528-32.
Hogan MJ, Swanwick GR, Kaiser J et al. Memory-related EEG power and coherence reductions in mild Alzheimer's disease. Int J Psychophysiol. 2003;49(2):147-63.
Huang C, Wahlund L, Dierks T et al. Discrimination of Alzheimer's disease and mild cognitive impairment by equivalent EEG sources: a cross-sectional and longitudinal study. Clin Neurophysiol. 2000;111(11):1961-7.
Hughes, C.P., Berg, L., Danziger, W.L. et al. A new clinical scale for the staging of dementia. Br. J. Psychiatry 1982;140:566–572.
Ihl R, Brinkmeyer J, Janner M et al. A comparison of ADAS and EEG in the discrimination of patients with dementia of the Alzheimer type from healthy controls. Neuropsychobiology. 2000;41(2):102-7.
Innocenti GM, Aggoun-Zouaoui D, Lehmann P. Cellular aspects of callosal connections and their development. Neuropsychologia 1995;33: 961–987
Jacobson SA, Leuchter AF, Walter DO. Conventional and quantitative EEG in the diagnosis of delirium among the elderly. J Neurol Neurosurg Psychiatry.
1993;56(2):153-8.
Jelic V, Shigeta M, Julin P et al. Quantitative electroencephalography power and
coherence in Alzheimer's disease and mild cognitive impairment. Dementia.
1996;7(6):314-23.
Jelic V, Dierks T, Amberla K et al. Longitudinal changes in quantitative EEG during long-term tacrine treatment of patients with Alzheimer's disease.
Neurosci Lett. 1998 Sep 25;254(2):85-8.
Jelic V, Johansson SE, Almkvist O et al. Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer's disease. Neurobiol Aging. 2000;21(4):533-40.
Johannesson G, Brun A, Gustafson I et al. EEG in presenile dementia related to cerebral blood flow and autopsy findings. Acta Neurol Scand. 1977;56(2):89-103.
Knott V, Engeland C, Mohr E et al. Acute nicotine administration in Alzheimer's disease: an exploratory EEG study. Neuropsychobiology. 2000;41(4):210-20.
Knott V, Mohr E, Mahoney C et al. Pharmaco-EEG test dose response predicts cholinesterase inhibitor treatment outcome in Alzheimer's disease. Methods Find Exp Clin Pharmacol. 2000;22(2):115-22.
Knott V, Mohr E, Mahoney C et al. Quantitative electroencephalography in Alzheimer's disease: comparison with a control group, population norms and mental status. J Psychiatry Neurosci. 2001;26(2):106-16.
Kogan EA, Korczyn AD, Virchovsky RG et al. EEG changes during long-term treatment with donepezil in Alzheimer's disease patients. J Neural Transm.
2001;108(10):1167-73.
Kuks JBM, Vos JE, O’Brien MJ. Coherence patterns of the infant sleep EEG in
absence of the corpus callosum. Electroencephalogr Clin Neurophysiol 1987;
66:8–14.
Kuskowski MA, Mortimer JA, Morley GK et al. Rate of cognitive decline in Alzheimer's disease is associated with EEG alpha power. Biol Psychiatry.
1993;33(8-9):659-62.
Leuchter AF, Spar JE, Walter Do et al. Electroencephalographic spectra and coherence in the diagnosis of Alzheimer's-type and multi-infarct dementia. A pilot study. Arch Gen Psychiatry. 1987;44(11):993-8.
Leuchter AF, Newton TF, Cook IA et al. Changes in brain functional connectivity in Alzheimer-type and multi-infarct dementia. Brain. 1992;115 ( Pt 5):1543-61.
Leuchter AF, Cook IA, Newton TF et al. Regional differences in brain electrical activity in dementia: use of spectral power and spectral ratio measures.
Electroencephalogr Clin Neurophysiol. 1993 Dec;87(6):385-93.
Lindau M, Jelic V, Johansson SE et al. Quantitative EEG abnormalities and cognitive dysfunctions in frontotemporal dementia and Alzheimer's disease.
Dement Geriatr Cogn Disord. 2003;15(2):106-14.
Liu CK.The epidemiology of dementia in Taiwan. Acta Neurol Taiwan.
2006;15(1):51-2.
Luders HO. Atlas and Classification of Electroencephalography. W.B. Saunders Company. 2000
Lyoo IK, Satlin A, Lee CK et al. Regional atrophy of the corpus callosum in subjects with Alzheimer's disease and multi-infarct dementia. Psychiatry Res.
1997;74(2):63-72.
McKhann G, Drachman D, Folstein M et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984
;34(7):939-44.
Micheloyannis S, Tzenaki M, Bamboukas M et al. Electroencephalographic evaluation of children without neuropsychiatric disturbances but with poor school performance. J Child Neurol. 1996;11(4):309-12.
Moretti DV, Babiloni C, Binetti G et al. Individual analysis of EEG frequency and band power in mild Alzheimer's disease. Clin Neurophysiol. 2004;115(2):299-308.
Musha T, Asada T, Yamashita F et al. A new EEG method for estimating cortical neuronal impairment that is sensitive to early stage Alzheimer's disease. Clin Neurophysiol. 2002;113(7):1052-8.
Naggara O, Oppenheim C, Rieu D et al. Diffusion tensor imaging in early Alzheimer's disease. Psychiatry Res. 2006;146(3):243-9.
Neufeld MY, Rabey MJ, Parmet Y et al. Effects of a single intravenous dose of scopolamine on the quantitative EEG in Alzheimer's disease patients and age-matched controls. Electroencephalogr Clin Neurophysiol. 1994;91(6):407-12.
Penttila M, Partanen JV, Soininen H et al. Quantitative analysis of occipital EEG in different stages of Alzheimer's disease. Electroencephalogr Clin
Neurophysiol. 1985;60(1):1-6.
Petersen RC, Smith GE, Waring SC et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56(3):303-8.
Pogarell O, Teipel SJ, Juckel G et al. EEG coherence reflects regional corpus callosum area in Alzheimer's disease. J Neurol Neurosurg Psychiatry.
2005;76(1):109-11.
Prichep LS, John ER, Ferris SH et al. Quantitative EEG correlates of cognitive deterioration in the elderly. Neurobiol Aging. 1994 ;15(1):85-90.
Prinz PN, Vitiello MV. Dominant occipital (alpha) rhythm frequency in early stage Alzheimer's disease and depression. Electroencephalogr Clin Neurophysiol.
1989;73(5):427-32.
Rae-Grant A, Blume W, Lau C et al. The electroencephalogram in Alzheimer-type dementia. A sequential study correlating the electroencephalogram with
psychometric and quantitative pathologic data. Arch Neurol. 1987;44(1):50-4.
Reisberg B, Ferris SH, De Leon MJ et al. The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry 1982;139:1136-1139.
Robinson DJ, Merskey H, Blume WT et al. Electroencephalography as an aid in the exclusion of Alzheimer's disease. Arch Neurol. 1994;51(3):280-4.
Rodriguez G, Nobili F, Arrigo A et al. Prognostic significance of quantitative electroencephalography in Alzheimer patients: preliminary observations.
Electroencephalogr Clin Neurophysiol. 1996;99(2):123-8.
Rodriguez G, Copello F, Vitali P et al. Clin Neurophysiol. EEG spectral profile to stage Alzheimer's disease. 1999;110(10):1831-7.
Roemer RA, Shagass C, Dubin W, Jaffe R, Siegal L. Quantitative EEG in elderly depressives. Brain Topogr. 1992;4(4):285-90.
Rose SE, Chen F, Chalk JB et al. Loss of connectivity in Alzheimer's disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging. J Neurol Neurosurg Psychiatry. 2000;69(4):528-30.
Shaw JC, Colter N, Resek G. EEG coherence, lateral preference and schizophrenia.
Psychological Med 1983; 13:299–306.
Sklar RL, Hanley J, Simmons WW. An EEG experiment aimed toward identifying dyslexic children. Nature 1972; 240:414–6.
Sloan EP, Fenton GW. EEG power spectra and cognitive change in geriatric psychiatry: a longitudinal study. Electroencephalogr Clin Neurophysiol. 1993 Jun;86(6):361-7.
Sneddon R, Shankle WR, Hara J et al. EEG detection of early Alzheimer's disease using psychophysical tasks. Clin EEG Neurosci. 2005;36(3):141-50.
Szelies B, Grond M, Herholz K et al. Quantitative EEG mapping and PET in Alzheimer's disease. J Neurol Sci. 1992;110(1-2):46-56.
Soininen H, Partanen JV, Puranen M et al. EEG and computed tomography in the investigation of patients with senile dementia. J Neurol Neurosurg Psychiatry.
1982;45(8):711-4.
Soininen H, Partanen J, Laulumaa V et al. Serial EEG in Alzheimer's disease: 3 year follow-up and clinical outcome. Electroencephalogr Clin Neurophysiol.
1991;79(5):342-8.
Sugihara S, Kinoshita T, Matsusue E et al. Usefulness of diffusion tensor
imaging of white matter in Alzheimer disease and vascular dementia. Acta Radiol.
2004;45(6):658-63.
Teng EL, Hasagawa K, Homma A et al. The Cognitive Abilities Screening Instrument (CASI): A practical Test for Cross Cultural Epidemiological Studies of Dementia.
Int Psychogeriat. 1994;6:45-58.
Teipel SJ, Bayer W, Alexander GE et al. Progression of corpus callosum atrophy in Alzheimer disease. Arch Neurol. 2002 Feb;59(2):243-8.
Teipel SJ, Bayer W, Alexander GE et al. Regional pattern of hippocampus and corpus callosum atrophy in Alzheimer's disease in relation to dementia severity:
evidence for early neocortical degeneration. Neurobiol Aging. 2003;24(1):85-94.
Thatcher RW, Krause PJ, Hrybyk M. Cortico-cortical associations and EEG coherence: a two-compartmental model. Electroencephalogr Clin Neurophysiol.
1986;64(2):123-43.
Vermersch P, Scheltens P, Barkhof F et al. Evidence for atrophy of the corpus callosum in Alzheimer's disease. Eur Neurol. 1994;34(2):83-6.
Wada Y, Nanbu Y, Kikuchi M et al. Abnormal functional connectivity in Alzheimer's disease: intrahemispheric EEG coherence during rest and photic stimulation. Eur Arch Psychiatry Clin Neurosci. 1998;248(4):203-8.
Walter DO. Coherence as a measure of relationship between EEG records.
Electroencephalogr Clin Neurophysiol. 1968;24(3):282.
Weis S, Jellinger K, Wenger E. Morphometry of the corpus callosum in normal aging and Alzheimer's disease. J Neural Transm Suppl. 1991;33:35-8.
Wilson WP, Musella L, Short MJ. The electroencephalogram in dementia. Contemp Neurol Ser. 1977;15:205-21.
Yamada K, Isotani T, Irisawa S et al. EEG Global Field Power spectrum changes after a single dose of atypical antipsychotics in healthy volunteers. Brain Topogr. 2004;16(4):281-5.
Yamauchi H, Fukuyama H, Nagahama Y et al. Comparison of the pattern of atrophy of the corpus callosum in frontotemporal dementia, progressive supranuclear palsy, and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2000;69(5):623-9.